Boothbay Fund Management’s Alimera Sciences ALIM Stock Holding History

Boothbay Fund Management’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,198,708	Closed	-$17.8M	–	2023
2024 Q2	$17.8M	Hold	3,198,708	–	–	0.42%	23
2024 Q1	$12.5M	Hold	3,198,708	–	–	0.24%	58
2023 Q4	$13.8M	Hold	3,198,708	–	–	0.35%	35
2023 Q3	$9.92M	Buy	+3,198,708	New	+$10.6M	0.24%	78
2020 Q1	–	Sell	-74,666	Closed	-$566K	–	1117
2019 Q4	$566K	Sell	74,666 -1	-0%	-$6	0.05%	458
2019 Q3	$634K	Hold	74,667	–	–	0.06%	409
2019 Q2	$997K	Buy	+74,667	New	+$1.05M	0.09%	267
2018 Q3	–	Sell	-1,295	Closed	-$19K	–	972
2018 Q2	$19K	Buy	+1,295	New	+$18.2K	﹤0.01%	723

Boothbay Fund Management's ALIM Position: Q3 2024 in Review

Boothbay Fund Management sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 3,198,708 shares — an estimated $17.8M sold.

Boothbay Fund Management first reported a position in ALIM in Q2 2018 and held it in 8 quarters. The position peaked at $17.8M in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

Boothbay Fund Management reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
Boothbay Fund Management sold 3,198,708 Alimera Sciences shares in Q3 2024, an estimated $17.8M.
Boothbay Fund Management first reported a position in Alimera Sciences in Q2 2018 and held it in 8 quarters.
Boothbay Fund Management's Alimera Sciences position peaked at $17.8M in Q2 2024.
0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Boothbay Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.